Ibrahim  Aldoss, M.D., is a hematologist-oncologist and board-certified in internal medicine, medical oncology and hematology. His clinical expertise is in acute lymphoblastic leukemia and acute myeloid leukemia.

Dr. Aldoss is also an associate professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, and an active Gehr Family Center Leukemia member. He is the co-director of the Hematology Tissue Bank at City of Hope and the co-director of the Leukemia Registry. His primary research focus is on optimizing treatment outcomes of younger adults with acute lymphocytic leukemia (ALL), improving immunotherapies in ALL, understanding methods of resistance, identifying alternate promising targets in ALL beyond CD19, improving transplant outcomes in ALL and understanding the genetics and the pathogenies of ALL. He is also the principal investigator on several novel therapies in acute leukemias.

Dr. Aldoss earned his medical degree from Jordan University of Science and Technology in Irbid, Jordan. He completed his residency in internal medicine at Creighton University in Omaha, Nebraska, before joining Keck School of Medicine of USC to pursue a fellowship in hematology/oncology. While at USC, Dr. Aldoss was chosen to be chief of hematology fellows and served as a clinical instructor. He joined City of Hope as a bone marrow transplantation fellow in 2014. He has published over 100 articles in the peer-reviewed literature, and he has presented his research work at many international meetings.